11630 SW 97 Street, Miami, Florida 33176, US

Advertising Driven Press Release Distribution

Tag:  Vaccines

Pneumococcal Vaccines Market, Size, Share, Evaluation, 2021-2028

Press Release

Market Overview The Global Pneumococcal Vaccines Market is expected to grow at a CAGR of 8.30% during the forecasting period (2021-2028). Pneumococcal Vaccines help prevent pneumococcal disease, which is a type of infection caused by Streptococcus pneumoniae bacteria. Pneumococcal disease is contagious […]

Read More>>

Curative Biotechnology, Inc. Names Marc Drimer, CPA to Board of Directors

Press Release

Appointment of Independent Director and Chairman of Audit Committee Expands Financial Expertise on Board Boca Raton, FL, July 20, 2021 — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development stage biomedical company focused on novel therapies […]

Read More>>

Curative Biotechnology, Inc. Announces Ticker Symbol Change to “CUBT” on OTC Markets

Press Release

Company Appoints Kapil Bharti, Ph.D., and Dimiter Dimitrov, Ph.D. to Scientific and Clinical Advisory Board Boca Raton, FL / iCrowd Newswire/ April 29, 2021 / Curative Biotechnology, Inc.  (OTC: CUBT) a development-stage biomedical company focused on novel therapies for rare diseases, announced today the […]

Read More>>

The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis

Press Release

Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list Roots Analysis is pleased to […]

Read More>>

Connectyx Technologies Holdings Group, Inc. Announces Definitive Agreement with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies

Press Release

Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases, announced today the Company has signed a definitive agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT) to acquire worldwide rights […]

Read More>>

Subscribe to Our Newsletter

For exclusive content regarding the latest trends in the world of Press Release distribution.